Details of the Drug Formulations

General Information of Drug (ID: DMOF2C6)

• Drug Name: Ecallantide Drug Info
• Synonyms: FOV-2302; Retinal venous occlusion therapy, Fovea; Ecallantide (ophthalmic formulation/retinal disease); Ecallantide (ophthalmic formulation/retinal disease), Dyax/Fovea; DX-88 (ophthalmic formulation/retinal disease), Dyax/Fovea

Indication

Disease Entry	ICD 11	Status	REF
Retina venous occlusion	9B74.1	Approved	[1]

• Cross-matching ID:
  PubChem CID: 44152182
  CAS Number: 460738-38-9
  TTD ID: D0P5AE
  ACDINA ID: D01026

Full List of Drug Formulations Containing This Drug

Ecallantide 10mg/ml injectable

Company	Formulation ID	FDA Description
Dyax Corp	F23143	Disodium Hydrogen Orthophosphate (Dihydrate); Monopotassium Phosphate; Potassium Chloride; Sodium Chloride In Water For Injection

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6955).